Types of Flu Vaccines

Proper Name: Influenza Virus Vaccine
Tradename: AFLURIA
Manufacturer:
CSL Limited, License No. 1764

Indication: For active immunization of adults 18 years of age and older against influenza disease caused by influenza virus subtypes A and type B present in the vaccine
Package insert 

Proper Name: Influenza Virus Vaccine, H5N1
Manufacturer:
Sanofi Pasteur Inc, License #1725

Indication: For active immunization of persons 18 through 64 years of age at increased risk of exposure to the H5N1 influenza virus subtype contained in the vaccine

Package Insert

Proper Name: Influenza Virus Vaccine
Tradename: FluLaval
Manufacturer: ID Biomedical Corporation of Quebec, License #1739

Package Insert

Proper Name: Influenza Virus Vaccine Live, Intranasal
Tradename: FluMist
Manufacturer:
MedImmune Vaccines, Inc, License #1652

Package Insert

 

Proper Name: Influenza Virus Vaccine
Tradename: Fluarix
Manufacturer:
GlaxoSmithKline Biologicals, License #1617

Package Insert

Proper Name: Influenza Virus Vaccine
Tradename: Fluvirin
Manufacturer:
Novartis Vaccines and Diagnostics Limited, License #1750

Package Insert 

Proper Name: Influenza Virus Vaccine
Tradename: Fluzone
Manufacturer:
Sanofi Pasteur, Inc, License #1725

Package Insert 

Thimerosal(mercury) Amounts:

Fluzone:

Fluzone, a sterile suspension for intramuscular injection, is supplied in four presentations: 

  •  Prefilled syringe, 0.25 mL, no preservative, pediatric dose, distinguished by a pink syringe plunger rod
  •  Prefilled syringe, 0.5 mL, no preservative
  • Single-dose vial, 0.5 mL, no preservative
  •  Multi-dose vial, 5 mL, contains thimerosal, a mercury derivative, added as a preservative. Each 0.5 mL dose contains 25 μg mercury.

Fluvirin:

DOSAGE FORMS AND STRENGTHS FLUVIRIN®, a sterile suspension for intramuscular injection, is supplied in two presentations:

  •   Prefilled syringe, 0.5-mL. Thimerosal, a mercury derivative used during manufacture, is removed by subsequent purification steps to a trace amount (≤ 1 mcg mercury per 0.5-mL dose).
  •   Multidose vial, 5-mL. Contains thimerosal, a mercury derivative (25 mcg mercury per 0.5-mL dose). Thimerosal is added as a preservative.

 Afluria:

AFLURIA®, a sterile suspension for intramuscular injection, is supplied in two presentations:

 

  •  0.5 mL preservative-free, single-dose, pre-filled syringe.
  •   5 mL multi-dose vial containing ten doses. Thimerosal, a mercury derivative, is added as a preservative; each 0.5 mL dose contains 24.5 micrograms (mcg) of mercury.

Flumist-intranasal and live:

  • 0.2 mL pre-filled, single-use intranasal spray (3) Each 0.2 mL dose contains 106.5-7.5 FFU (fluorescent focus units) of live attenuated influenza virus reassortants of each of the three strains for the 2008-2009 season: A/South Dakota/6/2007 (H1N1) (A/Brisbane/59/2007-like), A/Uruguay/716/2007 (H3N2) (A/Brisbane/10/2007-like), and B/Florida/4/2006.

 

Flulaval:

 

  •   Thimerosal, a mercury derivative, is added as a preservative. Each 0.5 mL dose contains 25 mcg mercury.

 

Fluarix:

 

  • Each 0.5 mL dose also contains octoxynol-10 (TRITON® X-100) ≤0.120 mg, α-tocopheryl hydrogen succinate ≤0.1 mg, and polysorbate 80 (Tween 80) ≤0.380 mg. The vaccine is formulated without preservatives.
  • Thimerosal is used at the early stages of manufacture and is removed by subsequent purification steps to a trace amount (≤1 mcg mercury per dose). Each dose may also contain residual amounts of hydrocortisone ≤0.0016 mcg, gentamicin sulfate ≤0.15 mcg, ovalbumin ≤1 mcg, formaldehyde ≤50 mcg, and sodium deoxycholate ≤50 mcg from the manufacturing process.

Follow

Get every new post delivered to your Inbox.